Study looks at effects of reducing intake of processed meat, unprocessed Red Meat
Jul 29, 2024
A 30% reduction in processed meat intake would lead to 352,900 fewer occurrences of type 2 diabetes and 92,500 fewer occurrences of cardiovascular disease.
Study: Professional medication review is a must when older adults want to scale back meds
By
Kristen Fischer
Jul 29, 2024
Many older adults want to cut back on taking multiple medications, or polypharmacy, but they need to talk to a clinician or pharmacist first, authors of a new report say.
Active commuters have lower risks for morbidity, mortality
Jul 17, 2024
Researchers examined prospective associations with multiple health outcomes over 18 years for pedestrians and cyclists using data for 82,297 individuals aged 16 to 74 years.
Experiencing gratitude tied to longevity in older women
Jul 08, 2024
Higher levels of gratitude were tied to a 9% reduction in all-cause mortality and a 15% reduction in cardiovascular death.
Almost half of US counties do not have practicing cardiologist
Jul 08, 2024
Counties without a cardiologist have a higher cardiovascular risk index, higher cardiovascular mortality rates and shorter life expectancy.
Nonphysician-implemented multifaceted intervention beneficial in HTN
Jun 20, 2024
Significant reductions were seen in total cardiovascular disease and all-cause mortality for those aged 60 years and older; significant reductions also were seen for those younger than 60 years.
Xylitol linked to incident major adverse cardiovascular event risk
Jun 17, 2024
The sweetener xylitol was linked to incident major adverse cardiovascular event risk in an initial untargeted metabolomics study and was confirmed in a validation cohort.
Planetary Health Diet Index linked to lower total, cause-specific mortality
Jun 10, 2024
Reductions seen in death from a variety of causes; PHDI scores were also associated with environmental impact
Semaglutide boosts kidney outcomes with obesity + cardiovascular disease
May 28, 2024
At the prespecified 104-week time point, semaglutide was associated with a lesser decline in eGFR than placebo.
Physical activity time, step counts yield similar results
May 21, 2024
Similar benefits were seen for all-cause mortality and cardiovascular disease prevention.